[en] Membrane type 1 metalloprotease (MT1-MMP) is a transmembrane metalloprotease that plays a major role in the extracellular matrix remodeling, directly by degrading several of its components and indirectly by activating pro-MMP2. We investigated the effects of MT1-MMP overexpression on in vitro and in vivo properties of human breast adenocarcinoma MCF7 cells, which do not express MT1-MMP or MMP-2. MT1-MMP and MMP-2 cDNAs were either transfected alone or cotransfected. All clones overexpressing MT1-MMP 1) were able to activate endogenous or exogenous pro-MMP-2, 2) displayed an enhanced in vitro invasiveness through matrigel-coated filters independent of MMP-2 transfection, 3) induced the rapid development of highly vascularized tumors when injected subcutaneously in nude mice, and 4) promoted blood vessels sprouting in the rat aortic ring assay. These effects were observed in all clones overexpressing MT1-MMP regardless of MMP-2 expression levels, suggesting that the production of MMP-2 by tumor cells themselves does not play a critical role in these events. The angiogenic phenotype of MT1-MMP-producing cells was associated with an up-regulation of VEGF expression. These results emphasize the importance of MT1-MMP during tumor angiogenesis and open new opportunities for the development of anti-angiogenic strategies combining inhibitors of MT1-MMP and VEGF antagonists.
Disciplines :
Biochemistry, biophysics & molecular biology
Author, co-author :
Sounni, Nor Eddine ; Université de Liège - ULiège > Département des sciences cliniques > Labo de biologie des tumeurs et du développement
Devy, L.
Hajitou, A.
Frankenne, Francis
Munaut, Carine ; Université de Liège - ULiège > Département des sciences cliniques > Labo de biologie des tumeurs et du développement
Gilles, Christine ; Université de Liège - ULiège > Département des sciences cliniques > Labo de biologie des tumeurs et du développement
Deroanne, Christophe ; Université de Liège - ULiège > Département des sciences biomédicales et précliniques > Protéines et glycoprot. de matr.extracell. et membran.basal.
Thompson, E. W.
Foidart, Jean-Michel ; Université de Liège - ULiège > Département des sciences cliniques > Gynécologie - Obstétrique
Noël, Agnès ; Université de Liège - ULiège > Département des sciences biomédicales et précliniques > Biologie cellulaire et moléculaire appliquée à l'homme
Language :
English
Title :
MT1-MMP expression promotes tumor growth and angiogenesis through an up-regulation of vascular endothelial growth factor expression
Publication date :
April 2002
Journal title :
FASEB Journal
ISSN :
0892-6638
eISSN :
1530-6860
Publisher :
Federation of American Society for Experimental Biology, Bethesda, United States - Maryland
Noel A., Gilles C., Bajou K., Devy L., Kebers F., Lewalle J.M., Maquoi E., Munaut C., Remacle A., Foidart J.M. (1997) Emerging roles for proteinases in cancer. Invasion Metastasis 17:221-239.
McCawley L.J., Matrisian L.M. (2000) Matrix metalloproteinases: Multifunctional contributors to tumor progression. Mol. Med Today 6:149-156.
Stetler-Stevenson W.G. (1999) Matrix metalloproteinases in angiogenesis: A moving target for therapeutic intervention. J. Clin. Invest. 103:1237-1241.
Sato H., Takino T., Okada Y., Cao J., Shinagawa A., Yamamoto E., Seiki M. (1994) A matrix metalloproteinase expressed on the surface of invasive tumour cells. Nature (London) 370:61-65.
D'Ortho M.P., Will H., Atkinson S., Butler G., Messent A., Gavrilovic J., Smith B., Timpl R., Zardi L., Murphy G. (1997) Membrane-type matrix metalloproteinases 1 and 2 exhibit broad-spectrum proteolytic capacities comparable to many matrix metalloproteinases. Eur. J. Biochem. 250:751-757.
Ohuchi E., Imai K., Fujii Y., Sato H., Seiki M., Okada Y. (1997) Membrane type 1 matrix metalloproteinase digests interstitial collagens and other extracellular matrix macromolecules. J. Biol. Chem. 272:2446-2451.
Koshikawa N., Giannelli G., Cirulli V., Miyazaki K., Quaranta V. (2000) Role of cell surface metalloprotease MT1-MMP in epithelial cell migration over laminin-5. J. Cell Biol. 148:615-624.
Hiraoka N., Allen E., Apel I.J., Gyetko M.R., Weiss S.J. (1998) Matrix metalloproteinases regulate neovascularization by acting as pericellular fibrinolysins. Cell 95:365-377.
Knauper V., Will H., Lopez-Otin C., Smith B., Atkinson S.J., Stanton H., Hembry R.M., Murphy G. (1996) Cellular mechanisms for human procollagenase-3 (MMP-13) activation. Evidence that MT1-MMP (MMP-14) and gelatinase a (MMP-2) are able to generate active enzyme. J. Biol. Chem. 271:17124-17131.
Strongin A.Y., Collier I., Bannikov G., Marmer B.L., Grant G.A., Goldberg G.I. (1995) Mechanism of cell surface activation of 72-kDa type IV collagenase. Isolation of the activated form of the membrane metalloprotease. J. Biol. Chem. 270:5331-5338.
Maquoi E., Frankenne F., Baramova E., Munaut C., Sounni N.E., Remacle A., Noel A., Murphy G., Foidart J.M. (2000) Membrane type 1 matrix metalloproteinase-associated degradation of tissue inhibitor of metalloproteinase 2 in human tumor cell lines. J. Biol. Chem. 275:11368-11378.
Tokuraku M., Sato H., Murakami S., Okada Y., Watanabe Y., Seiki M. (1995) Activation of the precursor of gelatinase A/72 kDa type IV collagenase/MMP-2 in lung carcinomas correlates with the expression of membrane-type matrix metalloproteinase (MT-MMP) and with lymph node metastasis. Int. J. Cancer 64:355-359.
Nawrocki B., Polette M., Marchand V., Monteau M., Gillery P., Tournier J.M., Birembaut P. (1997) Expression of matrix metalloproteinases and their inhibitors in human bronchopulmonary carcinomas: Quantitative and morphological analyses. Int. J. Cancer 72:556-564.
Nomura H., Sato H., Seiki M., Mai M., Okada Y. (1995) Expression of membrane-type matrix metalloproteinase in human gastric carcinomas. Cancer Res. 55:3263-3266.
Mori M., Mimori K., Shiraishi T., Fujie T., Baba K., Kusumoto H., Haraguchi M., Ueo H., Akiyoshi T. (1997) Analysis of MT1-MMP and MMP2 expression in human gastric cancers. Int. J. Cancer 74:316-321.
Okada A., Bellocq J.P., Rouyer N., Chenard M.P., Rio M.C., Chambon P., Basset P. (1995) Membrane-type matrix metalloproteinase (MT-MMP) gene is expressed in stromal cells of human colon, breast, and head and neck carcinomas. Proc. Natl. Acad. Sci. USA 92:2730-2734.
Ohtani H., Motohashi H., Sato H., Seiki M., Nagura H. (1996) Dual over-expression pattern of membrane-type metalloproteinase-1 in cancer and stromal cells in human gastrointestinal carcinoma revealed by in situ hybridization and immunoelectron microscopy. Int. J. Cancer 68:565-570.
Polette M., Nawrocki B., Gilles C., Sato H., Seiki M., Tournier J.M., Birembaut P. (1996) MT-MMP expression and localisation in human lung and breast cancers. Virchows Arch. 428:29-35.
Ueno H., Nakamura H., Inoue M., Imai K., Noguchi M., Sato H., Seiki M., Okada Y. (1997) Expression and tissue localization of membrane-types 1, 2, and 3 matrix metalloproteinases in human invasive breast carcinomas. Cancer Res. 57:2055-2060.
Gilles C., Polette M., Piette J., Munaut C., Thompson E.W., Birembaut P., Foidart J.M. (1996) High level of MT-MMP expression is associated with invasiveness of cervical cancer cells. Int. J. Cancer 65:209-213.
Belien A.T., Paganetti P.A., Schwab M.E. (1999) Membrane-type 1 matrix metalloprotease (MT1-MMP) enables invasive migration of glioma cells in central nervous system white matter. J. Cell Biol. 144:373-384.
Hofmann U.B., Westphal J.R., Zendman A.J., Becker J.C., Ruiter D.J., Van Muijen G.N. (2000) Expression and activation of matrix metalloproteinase-2 (MMP-2) and its colocalization with membrane-type 1 matrix metalloproteinase (MT1-MMP) correlate with melanoma progression. J. Pathol. 191:245-256.
Holmbeck K., Bianco P., Caterina J., Yamada S., Kromer M., Kuznetsov S.A., Mankani M., Robey P.G., Poole A.R., Pidoux I., Ward J.M., Birkedal-Hansen H. (1999) MT1-MMP-deficient mice develop dwarfism, osteopenia, arthritis, and connective tissue disease due to inadequate collagen turnover. Cell 99:81-92.
Zhou Z., Apte S.S., Soininen R., Cao R., Baaklini G.Y., Rauser R.W., Wang J., Cao Y., Tryggvason K. (2000) Impaired endochondral ossification and angiogenesis in mice deficient in membrane-type matrix metalloproteinase I. Proc. Natl. Acad. Sci. USA 97:4052-4057.
Schnaper H.W., Grant D.S., Stetler-Stevenson W.G., Fridman R., D'Orazi G., Murphy A.N., Bird R.E., Hoythya M., Fuerst T.R., French D.L. (1993) Type IV collagenase(s) and TIMPs modulate endothelial cell morphogenesis in vitro. J. Cell. Physiol. 156:235-246.
Hajitou A., Sounni N.E., Devy L., Grignet-Debrus C., Lewalle J.M., Li H., Deroanne C.F., Lu H., Colige A., Nusgens B.V., Frankenne F., Maron A., Yeh P., Perricaudet M., Chang Y., Soria C., Calberg-Bacq C.M., Foidart J.M., Noel A. (2001) Down-regulation of vascular endothelial growth factor by tissue inhibitor of metalloproteinase-2: Effect on in vivo mammary tumor growth and angiogenesis. Cancer Res. 61:3450-3457.
Sounni N.E., Baramova E.N., Munaut C., Maquoi E., Frankenne F., Foidart J.M., Noel A. (2001) Expression of membrane type 1 matrix metalloproteinase (MT1-MMP) in A2058 melanoma cells is associated with MMP-2 activation and increased tumor growth and vascularization. Int. J. Cancer, In press; .
Miller D.L., El Ashry D., Cheville A.L., Liu Y., McLeskey S.W., Kern F.G. (1994) Emergence of MCF-7 cells overexpressing a transfected epidermal growth factor receptor (EGFR) under estrogen-depleted conditions: Evidence for a role of EGFR in breast cancer growth and progression. Cell Growth Differ. 5:1263-1274.
Labarca C., Paigen K. (1980) A simple, rapid, and sensitive DNA assay procedure. Anal. Biochem. 102:344-352.
Noel A., Pauw-Gillet M.C., Purnell G., Nusgens B., Lapiere C.M., Foidart J.M. (1993) Enhancement of tumorigenicity of human breast adenocarcinoma cells in nude mice by matrigel and fibroblasts. Br. J. Cancer 68:909-915.
Bajou K., Noel A., Gerard R.D., Masson V., Brunner N., Holst-Hansen C., Skobe M., Fusenig N.E., Carmeliet P., Collen D., Foidart J.M. (1998) Absence of host plasminogen activator inhibitor 1 prevents cancer invasion and vascularization. Nat. Med. 4:923-928.
Nicosia R.F., Ottinetti A. (1990) Growth of microvessels in serum-free matrix culture of rat aorta. A quantitative assay of angiogenesis in vitro. Lab. Invest. 63:115-122.
Blacher S., Devy L., Burbridge M.F., Roland G., Tucker G., Noel A., Foidart J.M. (2001) Improved quantification of angiogenesis in the rat aortic ring assay. Angiogenesis 4:133-142.
Voyta J.C., Via D.P., Butterfield C.E., Zetter B.R. (1984) Identification and isolation of endothelial cells based on their increased uptake of acetylated-low density lipoprotein. J. Cell Biol. 99:2034-2040.
Rozanov D.V., Deryugina E.I., Ratnikov B.I., Monosov E.Z., Marchenko G.N., Quigley J.P., Strongin A.Y. (2001) Mutation analysis of membrane type-1 matrix metalloproteinase (MT1-MMP). The role of the cytoplasmic tail Cys(574), the active site Glu (240), and furin cleavage motifs in oligomerization, processing, and self-proteolysis of MT1-MMP expressed in breast carcinoma cells. J. Biol. Chem. 276:25705-25714.
Noel A., Emonard H., Polette M., Birembaut P., Foidart J.M. (1994) Role of matrix, fibroblasts and type IV collagenases in tumor progression and invasion. Pathol. Res. Pract. 190:934-941.
Polette M., Gilbert N., Stas I., Nawrocki B., Noel A., Remacle A., Stetler-Stevenson W.G., Birembaut P., Foidart M. (1994) Gelatinase A expression and localization in human breast cancers. An in situ hybridization study and immunohistochemical detection using confocal microscopy. Virchows Arch. 424:641-645.
Gingras D., Bousquet-Gagnon N., Langlois S., Lachambre M.P., Annabi B., Beliveau R. (2001) Activation of the extracellular signal-regulated protein kinase (ERK) cascade by membrane-type-1 matrix metalloproteinase (MT1-MMP). FEBS Lett. 507:231-236.
Deryugina E.I., Bourdon M.A., Jungwirth K., Smith J.W., Strongin A.Y. (2000) Functional activation of integrin alpha V beta 3 in tumor cells expressing membrane-type 1 matrix metalloproteinase. Int. J. Cancer 86:15-23.
Deryugina E.I., Ratnikov B., Monosov E., Postnova T.I., DiScipio R., Smith J.W., Strongin A.Y. (2001) MT1- MMP initiates activation of pro-MMP-2 and integrin alphavbeta3 promotes maturation of MMP-2 in breast carcinoma cells. Exp. Cell Res. 263:209-223.
Itoh T., Tanioka M., Yoshida H., Yoshioka T., Nishimoto H., Itohara S. (1998) Reduced angiogenesis and tumor progression in gelatinase A-deficient mice. Cancer Res. 58:1048-1051.
Fang J., Shing Y., Wiederschain D., Yan L., Butterfield C., Jackson G., Harper J., Tamvakopoulos G., Moses M.A. (2000) Matrix metalloproteinase-2 is required for the switch to the angiogenic phenotype in a tumor model. Proc. Natl. Acad. Sci. USA 97:3884-3889.
Coussens L.M., Tinkle C.L., Hanahan D., Werb Z. (2000) MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis. Cell 103:481-490.
Bergers G., Brekken R., McMahon G., Vu T.H., Itoh T., Tamaki K., Tanzawa K., Thorpe P., Itohara S., Werb Z., Hanahan D. (2000) Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. Nat. Cell Biol. 2:737-744.
